Professor, Urology, UCLA School of Medicine
Urology
Dr. Mark Litwin works in the field of Urology. He studied medicine at Emory University School of Medicine. Emory University School of Medicine is ranked 23/42 in Research/PrimaryCare. He received awards:"Alpha Omega Alpha", "Top Doctors:LA Area", "Top Doctors:Southern California", "Distinguished Service Award", "Whitmore Lecture", "Distinguished Mentor Award", "Leonard Tow Humanism in Medicine Award", "Outstanding Article of the Year Award nominee", "Franklin D. Murphy Prize for research demonstrating innovation and leadership", "Gold Cystoscope Award for outstanding contributions to urology", "Commencement Marshall", "Award for Excellence in Education", "Research Essay Contest, Third place winner", "Doctoring Program, Certificate of Distinction in Medical Education", "New Investigator Award", "Research Essay Contest, Second place winner", "Basic Science Prize, First place winner", "J. Hartwell Harrison Award in Urology", "Resident Research Contest, Second place winner", "Jerry L. Pettis Award for excellence in scientific communication", "Essay Award, First place winner", "Honorary Society for Collegiate Journalists" and "Fellow (FACS)". Dr. Mark Litwin is a published doctor as well. He has 54 publications published. The latest was: Burden of Geriatric Events Among Older Adults Undergoing Major Cancer Surgery. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- The relationship between intolerance of uncertainty and anxiety in men on active surveillance for prostate Cancer.
- Burden of Geriatric Events Among Older Adults Undergoing Major Cancer Surgery.
- Cancer surgeons and health system innovation: incentivizing change.
- Expectant management of veterans with early-stage prostate Cancer.
- Emergency Department Revisits for Patients with Kidney Stones in California.
- A Scalable Web-Based Module for Improving Surgical and Medical Practitioner Knowledge and Attitudes about Palliative and End-of-Life Care.
- Quality of diagnostic staging in patients with Bladder cancer: a process-outcomes link.
- Nationally representative trends and geographic variation in treatment of localized prostate Cancer: the Urologic Diseases in America project.
- Contemporary, age-based trends in the incidence and management of patients with early-stage kidney Cancer.
- Racial parity in tumor burden, treatment choice and survival outcomes in men with prostate Cancer in the VA healthcare system.
- An Age-Adjusted Comorbidity Index for Prediction of Long-Term, Other-Cause Mortality in Men with Prostate Cancer.
- Minimally important difference for the expanded prostate Cancer index composite short form.
- With Patient-reported Health Changing, Is It Time to Retool Our Instruments?
- Service Intensity and Physician Income: Conclusions From Medicare's Physician Data Release.
- Community-Partnered Collaboration to Build an Integrated Palliative Care Clinic: The View From Urology.
- Reply to Charlson score and competing mortality.
- Cardiovascular risk profile of veteran men beginning androgen deprivation therapy.
- Latino men and familial risk communication about prostate Cancer.
- Prediction of Long-term Other-cause Mortality in Men With Early-stage Prostate Cancer: Results From the Prostate Cancer Outcomes Study.
- Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate Cancer.
- Weighted Versus Unweighted Charlson Score to Predict Long-term Other-cause Mortality in Men with Early-stage Prostate Cancer.
- Decisional Conflict in Economically Disadvantaged Men With Newly Diagnosed Prostate Cancer: Baseline Results From a Shared Decision-Making Trial.
- Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate Cancer and differing comorbid disease burdens at diagnosis.
- Updated trends in imaging use in men diagnosed with prostate Cancer.
- The impact of unplanned postprocedure visits in the management of patients with urinary Stones.
- Measuring and Predicting Prostate Cancer Related Quality of Life Changes Using EPIC for Clinical Practice.
- The future of Bladder cancer care in the USA.
- The henderson-hasselbalch equation for urologists.
- Satisfaction with Information Used to Choose Prostate Cancer Treatment.
- Mapping a new truth.
- Use of imaging and biomarker tests for posttreatment care of early-stage breast Cancer survivors.
- Development of quality indicators for women with Urinary incontinence.
- Building a Medical Neighborhood in the Safety Net: An Innovative Technology Improves Hematuria Workups.
- Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study.
- Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments.
- Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate Cancer.
- Patterns of care in Testicular torsion: Influence of hospital transfer on Testicular outcomes.
- Recurrence of high-risk Bladder cancer: A population-based analysis.
- Urologist Attitudes Toward End-of-life Care.
- Quality-of-care indicators for pelvic organ prolapse: development of an infrastructure for quality assessment.
- Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate Cancer.
- Trends in the Surgical Management of Stress Urinary Incontinence Among Female Medicare Beneficiaries, 2002-2007.
- Body Mass Index and Prostate Cancer Severity: Do Obese Men Harbor More Aggressive Disease on Prostate Biopsy?
- Barriers to prostate Cancer care: affordable care is not enough.
- Differing perceptions of quality of life in patients with prostate Cancer and their doctors.
- Quality of life in men undergoing active surveillance for localized prostate Cancer.
- Hospice and emergency room use by disadvantaged men dying of prostate Cancer.
- Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis.
- The demographic burden of urologic Diseases in America.
- Prostate Cancer severity among low income, uninsured men.
- Pretreatment predictors of death from other causes in men with prostate Cancer.
- Determinants of treatment regret in low-income, uninsured men with prostate Cancer.
- Quality of life in men with locally advanced adenocarcinoma of the Prostate: an exploratory analysis using data from the CaPSURE database.
Schools
Emory University School Of Medicine
Brigham and Women39s Hospital
Harvard University
Procedures Preformed
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Kidney and Ureter Removal
- Kidney Stone Removal (Percutaneous Nephrostolithotomy, PCNL)
- Pelvic Exenteration (For: Gynecologic, Urinary, or Colorectal Malignancy)
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
Accepted Insurances
Awards
- Alpha Omega Alpha
- Top Doctors:LA Area
- Top Doctors:Southern California
- Distinguished Service Award
- Whitmore Lecture
- Distinguished Mentor Award
- Leonard Tow Humanism in Medicine Award
- Outstanding Article of the Year Award nominee
- Franklin D. Murphy Prize for research demonstrating innovation and leadership
- Gold Cystoscope Award for outstanding contributions to urology
- Commencement Marshall
- Award for Excellence in Education
- Research Essay Contest, Third place winner
- Doctoring Program, Certificate of Distinction in Medical Education
- New Investigator Award
- Research Essay Contest, Second place winner
- Basic Science Prize, First place winner
- J. Hartwell Harrison Award in Urology
- Resident Research Contest, Second place winner
- Jerry L. Pettis Award for excellence in scientific communication
- Essay Award, First place winner
- Honorary Society for Collegiate Journalists
- Fellow (FACS)
Education
-
Brigham and Women's Hospital
-
Emory University School of Medicine
-
Duke University
Hospital
-
Harbor-UCLA Medical Center
-
LAC-Olive View-UCLA Medical Center
-
Ronald Reagan UCLA Medical Center
-
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER |
|
1356369946 |
| NPPES Provider LastName |
|
LITWIN |
| NPPES Provider FirstName |
|
MARK |
| NPPES Provider ZIPCode |
|
900953075 |
| NPPES Provider State |
|
CA |
| Specialty Description |
|
Urology |
| Total Claim Count |
|
161.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1356369946 |
| Last Name Of The Provider |
LITWIN |
| First Name Of The Provider |
MARK |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
